We first determined MIAT expression level in 38 established leukemia/lymphoma cell lines including 7 B-cell acute lymphocytic leukemias with precursor B phenotype (BALL), one chronic lymphocytic leukemia (CLL), 10 acute myeloid leukemias (AML), one chronic myeloid leukemia (CML), 16 non-Hodgkin's lymphomas containing 8 diffuse large B cell lymphomas (DLBLs), 2 Follicular lymphomas (FL), and 6 Burkitt lymphomas, and 3 T-cell ALLs. This evidence concerns the gene MIAT and non-Hodgkin lymphoma.